Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Host nuclear factor-kappaB activation potentiates lung cancer metastasis.

Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Yull FE, Blackwell TS, Fingleton B.

Mol Cancer Res. 2008 Mar;6(3):364-71. doi: 10.1158/1541-7786.MCR-07-0309.

2.

Nuclear factor-kappaB: the enemy within.

Aggarwal BB.

Cancer Cell. 2004 Sep;6(3):203-8. Review.

3.

Nuclear factor-kappaB and tumor-associated macrophages.

Mancino A, Lawrence T.

Clin Cancer Res. 2010 Feb 1;16(3):784-9. doi: 10.1158/1078-0432.CCR-09-1015. Review.

4.

Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target.

Abdel-Latif MM, Kelleher D, Reynolds JV.

J Surg Res. 2009 May 1;153(1):172-80. doi: 10.1016/j.jss.2007.12.755. Review.

PMID:
18533190
5.

The role of NF-kappaB activation in the pathogenesis of acute pancreatitis.

Rakonczay Z Jr, Hegyi P, Takács T, McCarroll J, Saluja AK.

Gut. 2008 Feb;57(2):259-67. Review.

PMID:
17675325
6.

[NF-kappa B and prostatic adenocarcinoma].

Xiang ST, Guo H, Zhou SW.

Zhonghua Nan Ke Xue. 2003 Oct;9(7):536-8, 542. Review. Chinese.

PMID:
14628608
7.

NF-kappaB and the immune response.

Hayden MS, West AP, Ghosh S.

Oncogene. 2006 Oct 30;25(51):6758-80. Review.

PMID:
17072327
8.

Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?

Assenat E, Gerbal-chaloin S, Maurel P, Vilarem MJ, Pascussi JM.

Eur J Cancer. 2006 Apr;42(6):785-92. Review.

PMID:
16510279
9.

NF-kappaB inhibition: a double-edged sword in cancer?

Pikarsky E, Ben-Neriah Y.

Eur J Cancer. 2006 Apr;42(6):779-84. Review.

PMID:
16530406
10.

Nuclear factor kappa B and hepatitis viruses.

Guan YS, He Q, Wang MQ, Li P.

Expert Opin Ther Targets. 2008 Mar;12(3):265-80. doi: 10.1517/14728222.12.3.265. Review.

PMID:
18269337
11.

Inflammation meets cancer, with NF-κB as the matchmaker.

Ben-Neriah Y, Karin M.

Nat Immunol. 2011 Jul 19;12(8):715-23. doi: 10.1038/ni.2060. Review.

PMID:
21772280
12.

Macrophages and NF-κB in cancer.

Lawrence T.

Curr Top Microbiol Immunol. 2011;349:171-84. doi: 10.1007/82_2010_100. Review.

PMID:
21080151
13.

[Stimulation of the proliferation of metastatic cancer cells by environmental growth factors and cytokines].

Yamori T, Takeda K.

Gan To Kagaku Ryoho. 1999 Jul;26(8):1209-13. Review. Japanese.

PMID:
10431592
14.

The lung metastatic niche.

Maru Y.

J Mol Med (Berl). 2015 Nov;93(11):1185-92. Review.

PMID:
26489606
15.

[Advances of microRNAs correlated with invasion and metastasis of lung cancer].

You J, Zhou Q.

Zhongguo Fei Ai Za Zhi. 2010 Mar;13(3):265-9. doi: 10.3779/j.issn.1009-3419.2010.03.18. Review. Chinese. No abstract available.

16.

Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Gao D, Li S.

Pathol Oncol Res. 2014 Jan;20(1):27-42. doi: 10.1007/s12253-013-9734-x. Review.

PMID:
24357158
17.

The growth rate of human tumours.

Steel GG, Lamerton LF.

Br J Cancer. 1966 Mar;20(1):74-86. Review. No abstract available.

18.

Therapy of cancer metastasis by systemic activation of macrophages: from the bench to the clinic.

Fidler IJ, Kleinerman ES.

Res Immunol. 1993 May;144(4):284-7; discussion 294-8. Review. No abstract available.

PMID:
8378598
Items per page

Supplemental Content

Support Center